Black Diamond Therapeutics (BDTX) Q1 2026 Earnings

16MarConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.27
0.15
0.56
0.98

Details

Expected EPS
-0.178889
Actual EPS
-0.27
Surprise EPS
-0.09
Surprise Percent
+50.93%

Description

Black Diamond Therapeutics (BDTX) has reported earnings of -0.27 per share for Q1 2026.

0 Comments

Share your thoughts